Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Sigilon Therapeutics to Present at Upcoming Scientific and Investor Conferences

Sigilon Therapeutics
Posted on: 24 Feb 18

CAMBRIDGE, Mass., Feb. 23, 2018 /PRNewswire/ -- Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants, today announced that the company will present at the following upcoming conferences. Presentation details are as follows:

National Hemophilia Foundation 14th Workshop on Novel Technologies and Gene Transfer for Hemophilia


 

Presentation:  

Implantation of Immune Protected Cell Factories Protected by AfibromerTM Technology for the Treatment of Hemophilias 

Presenter:    

 David Peritt, Ph.D., Chief Technology Officer  

Date:  

Saturday, Feb. 24, 2018  

Time:  

10:45 a.m. EST 

Location:      

Capitol Hyatt Regency, Washington, D.C. 

BioCentury 25th Annual Future Leaders in the Biotech Industry Conference


 

Presenter:   

Paul Wotton, Ph.D., Chief Executive Officer  

Date:              

Friday, March 23, 2018 

Time:               

1:30 p.m. EDT  

Location:          

Millennium Broadway Hotel & Conference Center, New York  

About Sigilon Therapeutics

Founded and created by Flagship Pioneering, Sigilon Therapeutics is a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants for the treatment of chronic diseases. Treatments based on Sigilon Therapeutics' Afibromer™ technology platform include cell implants that act as responsive "living therapeutics," providing more natural control for diseases that are currently treated with intermittent injection or infusion. Initial areas of focus include hematologic, enzyme deficiency, endocrine and metabolic disorders. More natural control would restore health and free patients from the need for therapies that are disruptive to quality of life.

For more information please visit www.sigilon.com or follow on Twitter at https://twitter.com/Sigilon_Inc.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 24/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.